These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 19349574)

  • 1. Antipsychotic agents and cardiometabolic morbidity in youth.
    Kruszewski SP; Paczynski RP
    Arch Pediatr Adolesc Med; 2009 Apr; 163(4):394-5; author reply 395. PubMed ID: 19349574
    [No Abstract]   [Full Text] [Related]  

  • 2. Antipsychotic medications: metabolic and cardiovascular risk.
    Newcomer JW
    J Clin Psychiatry; 2007; 68 Suppl 4():8-13. PubMed ID: 17539694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical antipsychotics: enhancing healthy outcomes.
    Casey DE
    Arch Psychiatr Nurs; 2002 Jun; 16(3 Suppl 1):S12-9. PubMed ID: 12046020
    [No Abstract]   [Full Text] [Related]  

  • 4. Metabolic and cardiovascular adverse events associated with antipsychotic treatment in children and adolescents.
    McIntyre RS; Jerrell JM
    Arch Pediatr Adolesc Med; 2008 Oct; 162(10):929-35. PubMed ID: 18838645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Which comes first: atypical antipsychotic treatment or cardiometabolic risk?
    Stahl SM; Mignon L; Meyer JM
    Acta Psychiatr Scand; 2009 Mar; 119(3):171-9. PubMed ID: 19178394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consensus development conference on antipsychotic drugs and obesity and diabetes.
    ; ; ;
    Obes Res; 2004 Feb; 12(2):362-8. PubMed ID: 14981231
    [No Abstract]   [Full Text] [Related]  

  • 7. [Metabolic risk during antipsychotic treatment in patients with schizophrenia].
    Rzewuska M
    Psychiatr Pol; 2007; 41(4):457-72. PubMed ID: 18046977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipsychotic-induced weight gain and metabolic abnormalities: implications for increased mortality in patients with schizophrenia.
    Casey DE; Haupt DW; Newcomer JW; Henderson DC; Sernyak MJ; Davidson M; Lindenmayer JP; Manoukian SV; Banerji MA; Lebovitz HE; Hennekens CH
    J Clin Psychiatry; 2004; 65 Suppl 7():4-18; quiz 19-20. PubMed ID: 15151456
    [No Abstract]   [Full Text] [Related]  

  • 9. Weighing in: emergent diabetes mellitus and second-generation antipsychotics.
    Dufresne RL
    Ann Pharmacother; 2007 Oct; 41(10):1725-7. PubMed ID: 17785611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse events in children and adolescents treated with antipsychotic medications.
    Jerrell JM; McIntyre RS
    Hum Psychopharmacol; 2008 Jun; 23(4):283-90. PubMed ID: 18302312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The polycystic ovary syndrome--metabolic consequences].
    Tan S; Hahn S; Janssen OE
    Gynakol Geburtshilfliche Rundsch; 2008; 48(1):16-23. PubMed ID: 18209495
    [No Abstract]   [Full Text] [Related]  

  • 12. Primary care issues in patients with mental illness.
    Kiraly B; Gunning K; Leiser J
    Am Fam Physician; 2008 Aug; 78(3):355-62. PubMed ID: 18711951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Obesity, diabetes mellitus and metabolic syndrome: the implications for heart and the vascular system].
    Maisch B
    Herz; 2006 May; 31(3):185-8. PubMed ID: 16770553
    [No Abstract]   [Full Text] [Related]  

  • 14. Obesity and cardiometabolic syndrome in children.
    Velasquez-Mieyer P; Neira CP; Nieto R; Cowan PA
    Ther Adv Cardiovasc Dis; 2007 Oct; 1(1):61-81. PubMed ID: 19124396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The urgency of obesity].
    Salvador J
    Rev Med Univ Navarra; 2004; 48(2):9-10. PubMed ID: 15382607
    [No Abstract]   [Full Text] [Related]  

  • 16. Consensus development conference on antipsychotic drugs and obesity and diabetes.
    ; ; ;
    Diabetes Care; 2004 Feb; 27(2):596-601. PubMed ID: 14747245
    [No Abstract]   [Full Text] [Related]  

  • 17. Atypical antipsychotic-induced diabetes mellitus: an update on epidemiology and postulated mechanisms.
    Buchholz S; Morrow AF; Coleman PL
    Intern Med J; 2008 Jul; 38(7):602-6. PubMed ID: 18715305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of serious cardiac events in older adults using antipsychotic agents.
    Mehta S; Chen H; Johnson M; Aparasu RR
    Am J Geriatr Pharmacother; 2011 Apr; 9(2):120-32. PubMed ID: 21565711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Check up America: reduce cardiometabolic risk. Clinical tools of the American Diabetes Association.
    Armani AM
    Crit Pathw Cardiol; 2007 Jun; 6(2):60-3. PubMed ID: 17667866
    [No Abstract]   [Full Text] [Related]  

  • 20. [Atypical antipsychotic induced weight gain and metabolic disorders].
    Rojas G P; Poblete A C; Orellana G X; Rouliez A K; Liberman G C
    Rev Med Chil; 2009 Jan; 137(1):106-14. PubMed ID: 19399331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.